Data gathered during Innovative Medicines Initiative project DIRECT helped scientists to pinpoint genetic variants associated with a good response to diabetes drugs called GLP-1 agonists.
The EU’s Bulgarian commissioner officially leaves Brussels, with a mandate for a difficult task: trying to form a coalition government back home in Sofia after close elections
Talks between the European Commission and the UK government continue, as the argument about how much the UK pays to join the research programme drags on
To the alarm of mostly-US industry, the EU AI Act gets preliminary nod to control the emerging technology – and sets the stage for months of negotiations in Brussels and Washington
EIT Food will host the 5th edition of the EIT Food Annual Event “Transforming Food Systems” on 27-28 June 2023 in Riga, Latvia. The event is an exceptional opportunity for individuals and organizations interested in the future of food systems to learn, connect, and amplify their impact.
As negotiations on the EU plan to promote industrial data sharing continue, universities point to missed potential, while industry calls for a timeout. ‘We seem to be hurtling through the legislative process like a runaway train,’ says one lobby group
Research commissioner given unpaid leave from Brussels after she was nominated to be Bulgaria’s next prime minister. Research lobbyists say the timing is ‘particularly unfortunate’ as work begins to shape the next decade of R&I policy
Science expat networks in eastern Europe aim to turn brain drain into brain circulation, support mobility and narrow the gap between Widening countries and western Europe. But intermittent funding threatens the future of these grassroots initiatives
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.